stocktools
Offerings // Silo Pharma, Inc.

SILO offering history

Every offering-related filing in Silo Pharma, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 369 filings back to Mar 30, 2011.

Last executed offering
Jul 13, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Jul 24, 2026
S-3 — capacity, not a sale
Executed, last 12 months
6
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
Jul 24, 2026S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jul 13, 20268-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 16, 2026424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 15, 2026EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Apr 14, 2026424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 13, 2026EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Apr 2, 20268-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 23, 20268-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Nov 26, 2025424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 26, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Oct 29, 2025S-1REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 1, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 1, 20258-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 18, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 29, 20258-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 16, 2025424B4EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
May 15, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
May 9, 2025S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 29, 2025S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 25, 2025S-1REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 4, 2025424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 3, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Sep 4, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 3, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Aug 21, 2024S-1REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 31, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 30, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jul 25, 2024S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 22, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 22, 20248-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 17, 2024S-1REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jun 6, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 6, 20248-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 30, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jan 25, 2024S-3/AREGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Jan 23, 2024S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Sep 28, 2022424B4EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 26, 2022EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Sep 20, 2022S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Sep 9, 2022S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
SILO offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full SILO workspace →
SILO offering FAQ

When did SILO last execute an offering?

Per SEC filings, Silo Pharma, Inc.'s most recent priced offering document is a 8-K filed 2026-07-13. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did SILO last announce or register an offering?

The most recent registration is a S-3 filed 2026-07-24. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.